AKERO THERAPEUTICS INC (AKRO) Stock Balance Sheet
NASDAQ:AKRO - Nasdaq - US00973Y1082 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 185.92M | 340.24M | 234.21M | 249.80M | 150.50M | |||
| Marketable Securities | 500.37M | 402.84M | 315.80M | 101.70M | 37.80M | |||
| Other Current Assets | 27.00M | 27.00M | 9.95M | 3.70M | 5.30M | |||
| Total Current Assets | 713.00M | 770.00M | 560.00M | 355.20M | 193.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 690.00K | 760.00K | 1.03M | 1.30M | 1.50M | |||
| Investments And Advances | 442.00M | 55.00M | 19.00M | N/A | N/A | |||
| Other Non-Current Assets | N/A | 0.00 | 0.00 | 100.00K | 400.00K | |||
| Total Non-Current Assets | 443.00M | 56.00M | 20.00M | 1.40M | 1.90M | |||
| TOTAL ASSETS | 1.16B | 826.00M | 580.00M | 356.60M | 195.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.66M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 25.00M | 31.00M | 12.00M | 11.10M | 18.40M | |||
| Accounts Payable | 11.00M | 9.03M | 7.04M | 8.00M | 6.70M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 42.00M | 40.00M | 19.00M | 19.10M | 25.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 29.00M | 35.00M | 25.00M | 9.50M | 0.00 | |||
| Other Non-Current Liabilities | 750.00K | 720.00K | 870.00K | 1.40M | 1.30M | |||
| Total Non-Current Liabilities | 30.00M | 36.00M | 26.00M | 10.90M | 1.30M | |||
| TOTAL LIABILITIES | 72.00M | 76.00M | 45.00M | 30.00M | 26.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -897.00M | -826.00M | -574.00M | -422.30M | -310.30M | |||
| Additional Paid In Capital | 1.98B | 1.57B | 1.11B | 748.90M | 479.40M | |||
| Common Shares | 10.00K | 10.00K | 10.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 1.09M | 950.00K | 270.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 80.00M | 72.00M | 56.00M | 46.90M | 34.90M | |||
| Tangible Book Value per Share | 13.60 | 10.36 | 9.60 | 6.96 | 4.85 | |||
| Total Shareholders' Equity | 1.08B | 750.00M | 535.00M | 326.60M | 169.10M | |||
| TOTAL LIABILITIES AND EQUITY | 1.16B | 826.00M | 580.00M | 356.60M | 195.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.05 | 0.05 | 0.03 | N/A | |||
| Current Ratio | 16.98 | 19.25 | 29.47 | 18.60 | 7.71 | |||
| Return On Assets (ROA) | -23.36% | -30.51% | -26.21% | -31.42% | -51.55% | |||
| Return On Equity (ROE) | -24.91% | -33.60% | -28.41% | -34.30% | -59.60% | |||
All data in USD , ROIC based on taxRate of 0.21